Nontuberculous Mycobacteria Lung Disease: Management Strategies for Advanced Practice Providers

Nontuberculous mycobacterium lung disease (NTM-LD) is associated with significant morbidity and mortality with 5-year survival rates similar to that of patients with lung cancer. The incidence and prevalence of has risen dramatically in recent decades, straining the management capacity of the limited number of pulmonologist and infectious disease physicians. Thus, the role of advanced practice providers (APP), such as nurse practitioners and physician assistants, will become even more important as they take on more responsibilities in diagnosing and managing patients with NTM-LD. Based on recent conversations with NTM physicians and APPs, as well as practice pattern studies of pulmonologists, there are multiple gaps in knowledge, skills, and attitudes regarding the diagnosis and management of NTM-LD.

Nontuberculous Mycobacteria Lung Disease: Management Strategies for Advanced Practice Providers will address the gaps in NTM-LD care by reviewing current evidence-based criteria for diagnosis and recommendations for treatment. Content will be developed by expert physicians and APPs who manage patients with NTM-LD daily and understand the barriers and issues that APPs confront in the complex nature of NTM diagnosis and treatment.

Jointly provided by the Potomac Center for Medical Education and Rockpointe

In collaboration with

This activity is supported by an educational grant from Insmed.